nodes	percent_of_prediction	percent_of_DWPC	metapath
Polythiazide—SLC12A3—collecting duct of renal tubule—kidney cancer	0.298	0.557	CbGeAlD
Polythiazide—SLC12A3—nephron—kidney cancer	0.133	0.248	CbGeAlD
Polythiazide—SLC12A3—nephron tubule—kidney cancer	0.0287	0.0535	CbGeAlD
Polythiazide—SLC12A3—renal system—kidney cancer	0.0261	0.0487	CbGeAlD
Polythiazide—SLC12A3—kidney—kidney cancer	0.0252	0.047	CbGeAlD
Polythiazide—SLC12A3—cortex of kidney—kidney cancer	0.0245	0.0458	CbGeAlD
Polythiazide—Blood uric acid increased—Everolimus—kidney cancer	0.0061	0.0144	CcSEcCtD
Polythiazide—Hyperuricaemia—Sunitinib—kidney cancer	0.00539	0.0127	CcSEcCtD
Polythiazide—Blood uric acid increased—Sunitinib—kidney cancer	0.00509	0.012	CcSEcCtD
Polythiazide—Bendroflumethiazide—KCNMA1—kidney cancer	0.00499	0.124	CrCbGaD
Polythiazide—Pancreatitis—Pazopanib—kidney cancer	0.00467	0.011	CcSEcCtD
Polythiazide—Hyperuricaemia—Vincristine—kidney cancer	0.00456	0.0108	CcSEcCtD
Polythiazide—Hyperglycaemia—Temsirolimus—kidney cancer	0.00456	0.0107	CcSEcCtD
Polythiazide—Aplastic anaemia—Dactinomycin—kidney cancer	0.00445	0.0105	CcSEcCtD
Polythiazide—Photosensitivity reaction—Pazopanib—kidney cancer	0.00434	0.0102	CcSEcCtD
Polythiazide—Blood uric acid increased—Vincristine—kidney cancer	0.00431	0.0102	CcSEcCtD
Polythiazide—Jaundice—Pazopanib—kidney cancer	0.00414	0.00976	CcSEcCtD
Polythiazide—Vasculitis—Gemcitabine—kidney cancer	0.00411	0.0097	CcSEcCtD
Polythiazide—Pancreatitis—Everolimus—kidney cancer	0.00368	0.00869	CcSEcCtD
Polythiazide—Hydroflumethiazide—KCNMA1—kidney cancer	0.00356	0.088	CrCbGaD
Polythiazide—Pancreatitis—Erlotinib—kidney cancer	0.00355	0.00839	CcSEcCtD
Polythiazide—Hydrochlorothiazide—KCNMA1—kidney cancer	0.00346	0.0856	CrCbGaD
Polythiazide—Hyperglycaemia—Everolimus—kidney cancer	0.00339	0.008	CcSEcCtD
Polythiazide—Jaundice—Everolimus—kidney cancer	0.00327	0.0077	CcSEcCtD
Polythiazide—Pancreatitis—Sorafenib—kidney cancer	0.0032	0.00754	CcSEcCtD
Polythiazide—Muscle spasms—Pazopanib—kidney cancer	0.00319	0.00752	CcSEcCtD
Polythiazide—Leukopenia—Temsirolimus—kidney cancer	0.00315	0.00743	CcSEcCtD
Polythiazide—Agranulocytosis—Vinblastine—kidney cancer	0.00314	0.0074	CcSEcCtD
Polythiazide—Pancreatitis—Sunitinib—kidney cancer	0.00308	0.00726	CcSEcCtD
Polythiazide—Leukopenia—Pazopanib—kidney cancer	0.00297	0.007	CcSEcCtD
Polythiazide—Jaundice—Sorafenib—kidney cancer	0.00283	0.00669	CcSEcCtD
Polythiazide—Hyperglycaemia—Sunitinib—kidney cancer	0.00283	0.00668	CcSEcCtD
Polythiazide—Thrombocytopenia—Temsirolimus—kidney cancer	0.00281	0.00663	CcSEcCtD
Polythiazide—Anorexia—Temsirolimus—kidney cancer	0.00274	0.00646	CcSEcCtD
Polythiazide—Bendroflumethiazide—CA2—kidney cancer	0.00269	0.0666	CrCbGaD
Polythiazide—Thrombocytopenia—Pazopanib—kidney cancer	0.00265	0.00625	CcSEcCtD
Polythiazide—Anorexia—Pazopanib—kidney cancer	0.00258	0.00609	CcSEcCtD
Polythiazide—Benzthiazide—CA9—kidney cancer	0.00254	0.063	CrCbGaD
Polythiazide—Muscle spasms—Everolimus—kidney cancer	0.00252	0.00594	CcSEcCtD
Polythiazide—Decreased appetite—Temsirolimus—kidney cancer	0.0025	0.00589	CcSEcCtD
Polythiazide—Agranulocytosis—Dactinomycin—kidney cancer	0.00247	0.00583	CcSEcCtD
Polythiazide—Quinethazone—CA2—kidney cancer	0.00246	0.0609	CrCbGaD
Polythiazide—Constipation—Temsirolimus—kidney cancer	0.00246	0.00579	CcSEcCtD
Polythiazide—Paraesthesia—Pazopanib—kidney cancer	0.00243	0.00573	CcSEcCtD
Polythiazide—Photosensitivity reaction—Vincristine—kidney cancer	0.00242	0.00572	CcSEcCtD
Polythiazide—Agitation—Everolimus—kidney cancer	0.00241	0.00568	CcSEcCtD
Polythiazide—Vertigo—Vinblastine—kidney cancer	0.00236	0.00557	CcSEcCtD
Polythiazide—Methyclothiazide—CA2—kidney cancer	0.00236	0.0584	CrCbGaD
Polythiazide—Leukopenia—Vinblastine—kidney cancer	0.00235	0.00555	CcSEcCtD
Polythiazide—Decreased appetite—Pazopanib—kidney cancer	0.00235	0.00555	CcSEcCtD
Polythiazide—Leukopenia—Everolimus—kidney cancer	0.00234	0.00553	CcSEcCtD
Polythiazide—Cyclothiazide—CA2—kidney cancer	0.00229	0.0566	CrCbGaD
Polythiazide—Benzthiazide—CA2—kidney cancer	0.00229	0.0566	CrCbGaD
Polythiazide—Photosensitivity—Capecitabine—kidney cancer	0.00228	0.00538	CcSEcCtD
Polythiazide—Hyperglycaemia—Gemcitabine—kidney cancer	0.00227	0.00536	CcSEcCtD
Polythiazide—Chlorothiazide—CA2—kidney cancer	0.00227	0.0562	CrCbGaD
Polythiazide—Vascular purpura—Capecitabine—kidney cancer	0.00224	0.00528	CcSEcCtD
Polythiazide—Orthostatic hypotension—Paclitaxel—kidney cancer	0.00223	0.00526	CcSEcCtD
Polythiazide—Cramp muscle—Paclitaxel—kidney cancer	0.0022	0.00518	CcSEcCtD
Polythiazide—Glycosuria—Doxorubicin—kidney cancer	0.00219	0.00518	CcSEcCtD
Polythiazide—Muscle spasms—Sorafenib—kidney cancer	0.00219	0.00515	CcSEcCtD
Polythiazide—Hydroflumethiazide—CA9—kidney cancer	0.00213	0.0528	CrCbGaD
Polythiazide—Hypersensitivity—Temsirolimus—kidney cancer	0.00212	0.00499	CcSEcCtD
Polythiazide—Muscle spasms—Sunitinib—kidney cancer	0.0021	0.00496	CcSEcCtD
Polythiazide—Thrombocytopenia—Vinblastine—kidney cancer	0.0021	0.00495	CcSEcCtD
Polythiazide—Agranulocytosis—Gemcitabine—kidney cancer	0.0021	0.00494	CcSEcCtD
Polythiazide—Thrombocytopenia—Everolimus—kidney cancer	0.00209	0.00494	CcSEcCtD
Polythiazide—Purpura—Capecitabine—kidney cancer	0.00208	0.0049	CcSEcCtD
Polythiazide—Hydrochlorothiazide—CA9—kidney cancer	0.00207	0.0513	CrCbGaD
Polythiazide—Pancreatitis—Paclitaxel—kidney cancer	0.00207	0.00488	CcSEcCtD
Polythiazide—Asthenia—Temsirolimus—kidney cancer	0.00206	0.00486	CcSEcCtD
Polythiazide—Anorexia—Vinblastine—kidney cancer	0.00204	0.00482	CcSEcCtD
Polythiazide—Anorexia—Everolimus—kidney cancer	0.00204	0.0048	CcSEcCtD
Polythiazide—Leukopenia—Sorafenib—kidney cancer	0.00203	0.0048	CcSEcCtD
Polythiazide—Jaundice cholestatic—Doxorubicin—kidney cancer	0.00202	0.00477	CcSEcCtD
Polythiazide—Thrombocytopenia—Erlotinib—kidney cancer	0.00202	0.00476	CcSEcCtD
Polythiazide—Diarrhoea—Temsirolimus—kidney cancer	0.00197	0.00464	CcSEcCtD
Polythiazide—Anorexia—Erlotinib—kidney cancer	0.00197	0.00464	CcSEcCtD
Polythiazide—Leukopenia—Sunitinib—kidney cancer	0.00196	0.00462	CcSEcCtD
Polythiazide—Asthenia—Pazopanib—kidney cancer	0.00194	0.00458	CcSEcCtD
Polythiazide—Paraesthesia—Vinblastine—kidney cancer	0.00193	0.00454	CcSEcCtD
Polythiazide—Photosensitivity reaction—Paclitaxel—kidney cancer	0.00192	0.00454	CcSEcCtD
Polythiazide—Paraesthesia—Everolimus—kidney cancer	0.00192	0.00453	CcSEcCtD
Polythiazide—Hydroflumethiazide—CA2—kidney cancer	0.00192	0.0474	CrCbGaD
Polythiazide—Hyperuricaemia—Doxorubicin—kidney cancer	0.00192	0.00452	CcSEcCtD
Polythiazide—Hyperglycaemia—Paclitaxel—kidney cancer	0.0019	0.00449	CcSEcCtD
Polythiazide—Dizziness—Temsirolimus—kidney cancer	0.0019	0.00448	CcSEcCtD
Polythiazide—Decreased appetite—Vinblastine—kidney cancer	0.00186	0.0044	CcSEcCtD
Polythiazide—Hydrochlorothiazide—CA2—kidney cancer	0.00186	0.0461	CrCbGaD
Polythiazide—Decreased appetite—Everolimus—kidney cancer	0.00186	0.00438	CcSEcCtD
Polythiazide—Leukopenia—Dactinomycin—kidney cancer	0.00185	0.00437	CcSEcCtD
Polythiazide—Diarrhoea—Pazopanib—kidney cancer	0.00185	0.00437	CcSEcCtD
Polythiazide—Trichlormethiazide—CA9—kidney cancer	0.00185	0.0457	CrCbGaD
Polythiazide—Constipation—Vinblastine—kidney cancer	0.00183	0.00433	CcSEcCtD
Polythiazide—Orthostatic hypotension—Capecitabine—kidney cancer	0.00183	0.00431	CcSEcCtD
Polythiazide—Constipation—Everolimus—kidney cancer	0.00183	0.00431	CcSEcCtD
Polythiazide—Vomiting—Temsirolimus—kidney cancer	0.00183	0.00431	CcSEcCtD
Polythiazide—Thrombocytopenia—Sorafenib—kidney cancer	0.00182	0.00428	CcSEcCtD
Polythiazide—Rash—Temsirolimus—kidney cancer	0.00181	0.00427	CcSEcCtD
Polythiazide—Blood uric acid increased—Doxorubicin—kidney cancer	0.00181	0.00427	CcSEcCtD
Polythiazide—Dermatitis—Temsirolimus—kidney cancer	0.00181	0.00427	CcSEcCtD
Polythiazide—Headache—Temsirolimus—kidney cancer	0.0018	0.00425	CcSEcCtD
Polythiazide—Decreased appetite—Erlotinib—kidney cancer	0.00179	0.00423	CcSEcCtD
Polythiazide—Dizziness—Pazopanib—kidney cancer	0.00179	0.00422	CcSEcCtD
Polythiazide—Anorexia—Sorafenib—kidney cancer	0.00177	0.00417	CcSEcCtD
Polythiazide—Constipation—Erlotinib—kidney cancer	0.00176	0.00416	CcSEcCtD
Polythiazide—Thrombocytopenia—Sunitinib—kidney cancer	0.00175	0.00412	CcSEcCtD
Polythiazide—Vomiting—Pazopanib—kidney cancer	0.00172	0.00406	CcSEcCtD
Polythiazide—Rash—Pazopanib—kidney cancer	0.00171	0.00403	CcSEcCtD
Polythiazide—Nausea—Temsirolimus—kidney cancer	0.00171	0.00403	CcSEcCtD
Polythiazide—Dermatitis—Pazopanib—kidney cancer	0.0017	0.00402	CcSEcCtD
Polythiazide—Anorexia—Sunitinib—kidney cancer	0.0017	0.00401	CcSEcCtD
Polythiazide—Agitation—Vincristine—kidney cancer	0.0017	0.00401	CcSEcCtD
Polythiazide—Headache—Pazopanib—kidney cancer	0.0017	0.004	CcSEcCtD
Polythiazide—Aplastic anaemia—Doxorubicin—kidney cancer	0.00167	0.00394	CcSEcCtD
Polythiazide—Trichlormethiazide—CA2—kidney cancer	0.00166	0.0411	CrCbGaD
Polythiazide—Vertigo—Vincristine—kidney cancer	0.00166	0.00392	CcSEcCtD
Polythiazide—Leukopenia—Vincristine—kidney cancer	0.00166	0.00391	CcSEcCtD
Polythiazide—Thrombocytopenia—Dactinomycin—kidney cancer	0.00165	0.0039	CcSEcCtD
Polythiazide—Decreased appetite—Sorafenib—kidney cancer	0.00161	0.0038	CcSEcCtD
Polythiazide—Anorexia—Dactinomycin—kidney cancer	0.00161	0.0038	CcSEcCtD
Polythiazide—Nausea—Pazopanib—kidney cancer	0.00161	0.00379	CcSEcCtD
Polythiazide—Paraesthesia—Sunitinib—kidney cancer	0.0016	0.00378	CcSEcCtD
Polythiazide—Constipation—Sorafenib—kidney cancer	0.00159	0.00374	CcSEcCtD
Polythiazide—Hypersensitivity—Vinblastine—kidney cancer	0.00158	0.00373	CcSEcCtD
Polythiazide—Photosensitivity reaction—Capecitabine—kidney cancer	0.00158	0.00373	CcSEcCtD
Polythiazide—Hypersensitivity—Everolimus—kidney cancer	0.00157	0.00371	CcSEcCtD
Polythiazide—Leukopenia—Gemcitabine—kidney cancer	0.00157	0.00371	CcSEcCtD
Polythiazide—Hyperglycaemia—Capecitabine—kidney cancer	0.00156	0.00368	CcSEcCtD
Polythiazide—Decreased appetite—Sunitinib—kidney cancer	0.00155	0.00366	CcSEcCtD
Polythiazide—Asthenia—Vinblastine—kidney cancer	0.00154	0.00363	CcSEcCtD
Polythiazide—Asthenia—Everolimus—kidney cancer	0.00153	0.00362	CcSEcCtD
Polythiazide—Constipation—Sunitinib—kidney cancer	0.00153	0.0036	CcSEcCtD
Polythiazide—Jaundice—Capecitabine—kidney cancer	0.0015	0.00355	CcSEcCtD
Polythiazide—Asthenia—Erlotinib—kidney cancer	0.00148	0.00349	CcSEcCtD
Polythiazide—Thrombocytopenia—Vincristine—kidney cancer	0.00148	0.00349	CcSEcCtD
Polythiazide—Urticaria—Sorafenib—kidney cancer	0.00147	0.00348	CcSEcCtD
Polythiazide—Photosensitivity—Doxorubicin—kidney cancer	0.00147	0.00347	CcSEcCtD
Polythiazide—Decreased appetite—Dactinomycin—kidney cancer	0.00147	0.00346	CcSEcCtD
Polythiazide—Diarrhoea—Vinblastine—kidney cancer	0.00147	0.00346	CcSEcCtD
Polythiazide—Diarrhoea—Everolimus—kidney cancer	0.00146	0.00345	CcSEcCtD
Polythiazide—Vascular purpura—Doxorubicin—kidney cancer	0.00144	0.0034	CcSEcCtD
Polythiazide—Agranulocytosis—Capecitabine—kidney cancer	0.00144	0.0034	CcSEcCtD
Polythiazide—Anorexia—Vincristine—kidney cancer	0.00144	0.00339	CcSEcCtD
Polythiazide—Dizziness—Vinblastine—kidney cancer	0.00142	0.00335	CcSEcCtD
Polythiazide—Dizziness—Everolimus—kidney cancer	0.00141	0.00333	CcSEcCtD
Polythiazide—Muscle spasms—Paclitaxel—kidney cancer	0.00141	0.00333	CcSEcCtD
Polythiazide—Diarrhoea—Erlotinib—kidney cancer	0.00141	0.00333	CcSEcCtD
Polythiazide—Thrombocytopenia—Gemcitabine—kidney cancer	0.0014	0.00331	CcSEcCtD
Polythiazide—Hypersensitivity—Sorafenib—kidney cancer	0.00137	0.00322	CcSEcCtD
Polythiazide—Anorexia—Gemcitabine—kidney cancer	0.00137	0.00322	CcSEcCtD
Polythiazide—Vomiting—Vinblastine—kidney cancer	0.00136	0.00322	CcSEcCtD
Polythiazide—Dizziness—Erlotinib—kidney cancer	0.00136	0.00322	CcSEcCtD
Polythiazide—Vomiting—Everolimus—kidney cancer	0.00136	0.0032	CcSEcCtD
Polythiazide—Paraesthesia—Vincristine—kidney cancer	0.00136	0.0032	CcSEcCtD
Polythiazide—Agitation—Paclitaxel—kidney cancer	0.00135	0.00318	CcSEcCtD
Polythiazide—Rash—Everolimus—kidney cancer	0.00135	0.00318	CcSEcCtD
Polythiazide—Dermatitis—Everolimus—kidney cancer	0.00135	0.00318	CcSEcCtD
Polythiazide—Headache—Vinblastine—kidney cancer	0.00134	0.00317	CcSEcCtD
Polythiazide—Purpura—Doxorubicin—kidney cancer	0.00134	0.00316	CcSEcCtD
Polythiazide—Headache—Everolimus—kidney cancer	0.00134	0.00316	CcSEcCtD
Polythiazide—Asthenia—Sorafenib—kidney cancer	0.00133	0.00314	CcSEcCtD
Polythiazide—Vertigo—Paclitaxel—kidney cancer	0.00132	0.00311	CcSEcCtD
Polythiazide—Leukopenia—Paclitaxel—kidney cancer	0.00132	0.0031	CcSEcCtD
Polythiazide—Hypersensitivity—Sunitinib—kidney cancer	0.00132	0.0031	CcSEcCtD
Polythiazide—Decreased appetite—Vincristine—kidney cancer	0.00131	0.0031	CcSEcCtD
Polythiazide—Vomiting—Erlotinib—kidney cancer	0.00131	0.00309	CcSEcCtD
Polythiazide—Rash—Erlotinib—kidney cancer	0.0013	0.00307	CcSEcCtD
Polythiazide—Dermatitis—Erlotinib—kidney cancer	0.0013	0.00306	CcSEcCtD
Polythiazide—Headache—Erlotinib—kidney cancer	0.00129	0.00305	CcSEcCtD
Polythiazide—Constipation—Vincristine—kidney cancer	0.00129	0.00305	CcSEcCtD
Polythiazide—Paraesthesia—Gemcitabine—kidney cancer	0.00129	0.00303	CcSEcCtD
Polythiazide—Asthenia—Sunitinib—kidney cancer	0.00128	0.00302	CcSEcCtD
Polythiazide—Nausea—Vinblastine—kidney cancer	0.00127	0.00301	CcSEcCtD
Polythiazide—Nausea—Everolimus—kidney cancer	0.00127	0.00299	CcSEcCtD
Polythiazide—Diarrhoea—Sorafenib—kidney cancer	0.00127	0.00299	CcSEcCtD
Polythiazide—Decreased appetite—Gemcitabine—kidney cancer	0.00124	0.00294	CcSEcCtD
Polythiazide—Hypersensitivity—Dactinomycin—kidney cancer	0.00124	0.00294	CcSEcCtD
Polythiazide—Dizziness—Sorafenib—kidney cancer	0.00123	0.00289	CcSEcCtD
Polythiazide—Constipation—Gemcitabine—kidney cancer	0.00122	0.00289	CcSEcCtD
Polythiazide—Nausea—Erlotinib—kidney cancer	0.00122	0.00289	CcSEcCtD
Polythiazide—Diarrhoea—Sunitinib—kidney cancer	0.00122	0.00288	CcSEcCtD
Polythiazide—Asthenia—Dactinomycin—kidney cancer	0.00121	0.00286	CcSEcCtD
Polythiazide—Dizziness—Sunitinib—kidney cancer	0.00118	0.00278	CcSEcCtD
Polythiazide—Vomiting—Sorafenib—kidney cancer	0.00118	0.00278	CcSEcCtD
Polythiazide—Orthostatic hypotension—Doxorubicin—kidney cancer	0.00118	0.00278	CcSEcCtD
Polythiazide—Thrombocytopenia—Paclitaxel—kidney cancer	0.00117	0.00277	CcSEcCtD
Polythiazide—Rash—Sorafenib—kidney cancer	0.00117	0.00276	CcSEcCtD
Polythiazide—Dermatitis—Sorafenib—kidney cancer	0.00117	0.00276	CcSEcCtD
Polythiazide—Headache—Sorafenib—kidney cancer	0.00116	0.00274	CcSEcCtD
Polythiazide—Muscle spasms—Capecitabine—kidney cancer	0.00116	0.00273	CcSEcCtD
Polythiazide—Diarrhoea—Dactinomycin—kidney cancer	0.00116	0.00273	CcSEcCtD
Polythiazide—Anorexia—Paclitaxel—kidney cancer	0.00114	0.0027	CcSEcCtD
Polythiazide—Vomiting—Sunitinib—kidney cancer	0.00113	0.00268	CcSEcCtD
Polythiazide—Rash—Sunitinib—kidney cancer	0.00113	0.00265	CcSEcCtD
Polythiazide—Dermatitis—Sunitinib—kidney cancer	0.00112	0.00265	CcSEcCtD
Polythiazide—Headache—Sunitinib—kidney cancer	0.00112	0.00264	CcSEcCtD
Polythiazide—Hypersensitivity—Vincristine—kidney cancer	0.00111	0.00262	CcSEcCtD
Polythiazide—Nausea—Sorafenib—kidney cancer	0.0011	0.0026	CcSEcCtD
Polythiazide—Pancreatitis—Doxorubicin—kidney cancer	0.00109	0.00258	CcSEcCtD
Polythiazide—Vertigo—Capecitabine—kidney cancer	0.00108	0.00256	CcSEcCtD
Polythiazide—Asthenia—Vincristine—kidney cancer	0.00108	0.00256	CcSEcCtD
Polythiazide—Leukopenia—Capecitabine—kidney cancer	0.00108	0.00255	CcSEcCtD
Polythiazide—Paraesthesia—Paclitaxel—kidney cancer	0.00108	0.00254	CcSEcCtD
Polythiazide—Vomiting—Dactinomycin—kidney cancer	0.00107	0.00253	CcSEcCtD
Polythiazide—Rash—Dactinomycin—kidney cancer	0.00107	0.00251	CcSEcCtD
Polythiazide—Nausea—Sunitinib—kidney cancer	0.00106	0.0025	CcSEcCtD
Polythiazide—Decreased appetite—Paclitaxel—kidney cancer	0.00104	0.00246	CcSEcCtD
Polythiazide—Diarrhoea—Vincristine—kidney cancer	0.00103	0.00244	CcSEcCtD
Polythiazide—Asthenia—Gemcitabine—kidney cancer	0.00103	0.00242	CcSEcCtD
Polythiazide—Constipation—Paclitaxel—kidney cancer	0.00103	0.00242	CcSEcCtD
Polythiazide—Photosensitivity reaction—Doxorubicin—kidney cancer	0.00102	0.0024	CcSEcCtD
Polythiazide—Hyperglycaemia—Doxorubicin—kidney cancer	0.00101	0.00237	CcSEcCtD
Polythiazide—Nausea—Dactinomycin—kidney cancer	0.001	0.00237	CcSEcCtD
Polythiazide—Dizziness—Vincristine—kidney cancer	0.000998	0.00235	CcSEcCtD
Polythiazide—Diarrhoea—Gemcitabine—kidney cancer	0.00098	0.00231	CcSEcCtD
Polythiazide—Jaundice—Doxorubicin—kidney cancer	0.000969	0.00229	CcSEcCtD
Polythiazide—Thrombocytopenia—Capecitabine—kidney cancer	0.000963	0.00227	CcSEcCtD
Polythiazide—Vomiting—Vincristine—kidney cancer	0.00096	0.00226	CcSEcCtD
Polythiazide—Urticaria—Paclitaxel—kidney cancer	0.000953	0.00225	CcSEcCtD
Polythiazide—Rash—Vincristine—kidney cancer	0.000952	0.00225	CcSEcCtD
Polythiazide—Dermatitis—Vincristine—kidney cancer	0.000951	0.00224	CcSEcCtD
Polythiazide—Headache—Vincristine—kidney cancer	0.000946	0.00223	CcSEcCtD
Polythiazide—Anorexia—Capecitabine—kidney cancer	0.000938	0.00221	CcSEcCtD
Polythiazide—Agranulocytosis—Doxorubicin—kidney cancer	0.000928	0.00219	CcSEcCtD
Polythiazide—Vomiting—Gemcitabine—kidney cancer	0.000911	0.00215	CcSEcCtD
Polythiazide—Rash—Gemcitabine—kidney cancer	0.000903	0.00213	CcSEcCtD
Polythiazide—Dermatitis—Gemcitabine—kidney cancer	0.000902	0.00213	CcSEcCtD
Polythiazide—Headache—Gemcitabine—kidney cancer	0.000897	0.00212	CcSEcCtD
Polythiazide—Nausea—Vincristine—kidney cancer	0.000897	0.00212	CcSEcCtD
Polythiazide—Paraesthesia—Capecitabine—kidney cancer	0.000884	0.00208	CcSEcCtD
Polythiazide—Hypersensitivity—Paclitaxel—kidney cancer	0.000883	0.00208	CcSEcCtD
Polythiazide—Asthenia—Paclitaxel—kidney cancer	0.00086	0.00203	CcSEcCtD
Polythiazide—Decreased appetite—Capecitabine—kidney cancer	0.000855	0.00202	CcSEcCtD
Polythiazide—Nausea—Gemcitabine—kidney cancer	0.000851	0.00201	CcSEcCtD
Polythiazide—Constipation—Capecitabine—kidney cancer	0.000841	0.00198	CcSEcCtD
Polythiazide—Diarrhoea—Paclitaxel—kidney cancer	0.00082	0.00194	CcSEcCtD
Polythiazide—Dizziness—Paclitaxel—kidney cancer	0.000793	0.00187	CcSEcCtD
Polythiazide—Urticaria—Capecitabine—kidney cancer	0.000782	0.00184	CcSEcCtD
Polythiazide—Vomiting—Paclitaxel—kidney cancer	0.000762	0.0018	CcSEcCtD
Polythiazide—Rash—Paclitaxel—kidney cancer	0.000756	0.00178	CcSEcCtD
Polythiazide—Dermatitis—Paclitaxel—kidney cancer	0.000755	0.00178	CcSEcCtD
Polythiazide—Headache—Paclitaxel—kidney cancer	0.000751	0.00177	CcSEcCtD
Polythiazide—Muscle spasms—Doxorubicin—kidney cancer	0.000747	0.00176	CcSEcCtD
Polythiazide—Hypersensitivity—Capecitabine—kidney cancer	0.000725	0.00171	CcSEcCtD
Polythiazide—Agitation—Doxorubicin—kidney cancer	0.000714	0.00168	CcSEcCtD
Polythiazide—Nausea—Paclitaxel—kidney cancer	0.000712	0.00168	CcSEcCtD
Polythiazide—Asthenia—Capecitabine—kidney cancer	0.000706	0.00167	CcSEcCtD
Polythiazide—Vertigo—Doxorubicin—kidney cancer	0.000698	0.00165	CcSEcCtD
Polythiazide—Leukopenia—Doxorubicin—kidney cancer	0.000696	0.00164	CcSEcCtD
Polythiazide—Diarrhoea—Capecitabine—kidney cancer	0.000673	0.00159	CcSEcCtD
Polythiazide—Dizziness—Capecitabine—kidney cancer	0.000651	0.00153	CcSEcCtD
Polythiazide—Vomiting—Capecitabine—kidney cancer	0.000626	0.00148	CcSEcCtD
Polythiazide—Thrombocytopenia—Doxorubicin—kidney cancer	0.000621	0.00146	CcSEcCtD
Polythiazide—Rash—Capecitabine—kidney cancer	0.00062	0.00146	CcSEcCtD
Polythiazide—Dermatitis—Capecitabine—kidney cancer	0.00062	0.00146	CcSEcCtD
Polythiazide—Headache—Capecitabine—kidney cancer	0.000616	0.00145	CcSEcCtD
Polythiazide—Anorexia—Doxorubicin—kidney cancer	0.000605	0.00143	CcSEcCtD
Polythiazide—Nausea—Capecitabine—kidney cancer	0.000584	0.00138	CcSEcCtD
Polythiazide—Paraesthesia—Doxorubicin—kidney cancer	0.00057	0.00134	CcSEcCtD
Polythiazide—Decreased appetite—Doxorubicin—kidney cancer	0.000551	0.0013	CcSEcCtD
Polythiazide—Constipation—Doxorubicin—kidney cancer	0.000542	0.00128	CcSEcCtD
Polythiazide—Urticaria—Doxorubicin—kidney cancer	0.000504	0.00119	CcSEcCtD
Polythiazide—Hypersensitivity—Doxorubicin—kidney cancer	0.000467	0.0011	CcSEcCtD
Polythiazide—Asthenia—Doxorubicin—kidney cancer	0.000455	0.00107	CcSEcCtD
Polythiazide—Diarrhoea—Doxorubicin—kidney cancer	0.000434	0.00102	CcSEcCtD
Polythiazide—Dizziness—Doxorubicin—kidney cancer	0.000419	0.000989	CcSEcCtD
Polythiazide—Vomiting—Doxorubicin—kidney cancer	0.000403	0.000951	CcSEcCtD
Polythiazide—Rash—Doxorubicin—kidney cancer	0.0004	0.000943	CcSEcCtD
Polythiazide—Dermatitis—Doxorubicin—kidney cancer	0.0004	0.000943	CcSEcCtD
Polythiazide—Headache—Doxorubicin—kidney cancer	0.000397	0.000937	CcSEcCtD
Polythiazide—Nausea—Doxorubicin—kidney cancer	0.000377	0.000889	CcSEcCtD
